Related Experiment Video
Updated: May 3, 2026
08:01
Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
Published on: November 4, 2016
11.4K
Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.
The Journal of Clinical Investigation
|January 28, 2014
Summary
Systemic lupus erythematosus (SLE) involves altered lipid metabolism in CD4+ T cells, with increased glycosphingolipids (GSLs). Targeting GSL biosynthesis corrects T cell defects and reduces autoantibody production in SLE patients.
Area of Science:
- Immunology
- Metabolic pathways
- Autoimmune diseases
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by defects in lymphocyte signaling and function.
- These defects may stem from altered metabolic processes, particularly lipid biosynthesis pathways.
Purpose of the Study:
- To investigate the role of lipid metabolism, specifically glycosphingolipids (GSLs), in the pathogenesis of SLE.
- To explore the potential of targeting GSL biosynthesis for therapeutic intervention in SLE.
Main Methods:
- Analysis of GSL profiles in CD4+ T cells from SLE patients and healthy controls.
- Investigated the role of liver X receptor beta (LXRβ) in regulating GSL expression.
- Utilized N-butyldeoxynojirimycin, a GSL biosynthesis inhibitor, to assess its impact on T cell function and autoantibody production.
Main Results:
- CD4+ T cells from SLE patients showed elevated levels of specific GSLs (lactosylceramide, Gb3, GM1) compared to controls.
- Increased GSLs correlated with higher LXRβ expression and were promoted by LXR agonists.
- Inhibition of GSL biosynthesis normalized T cell metabolism and function, and reduced anti-dsDNA antibody production.
Conclusions:
- Altered lipid metabolism, specifically GSL accumulation, contributes to SLE pathogenesis.
- Targeting GSL biosynthesis represents a potential therapeutic strategy to restore T cell function in SLE.
